ANEMIA PREDICTS SUSTAINED VIROLOGIC RESPONSE IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN FOUR CLINICAL TRIALS

被引:0
|
作者
Reau, N. [1 ]
Korner, E. J. [2 ]
Han, J. [2 ]
Jensen, D. M. [1 ]
机构
[1] Univ Chicago Hosp, Ctr Liver Dis, Chicago, IL 60637 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0168-8278(13)60894-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
892
引用
收藏
页码:S367 / S367
页数:1
相关论文
共 50 条
  • [31] Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 157 - 159
  • [32] Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin
    Mauss, Stefan
    Schober, Andreas
    Lutz, Thomas
    Moog, Gero
    Schuchmann, Marcus
    Heyne, Renate
    John, Christine
    Schiffelholz, Willibold
    Baumgarten, Axel
    Hey, Karl-Heinz
    Eisenbach, Christoph
    Teuber, Gerlinde
    Schmidt, Wolfgang
    Bruch, Harald-Robert
    Geyer, Peter
    Alshuth, Ulrich
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2011, 140 (05) : S948 - S948
  • [33] Association of pretreatment and on-treatment factors with null response in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin
    DiBisceglie, A. M.
    Hassanein, T. I.
    Jeffers, L. J.
    Hamzeh, F. M.
    Lindsay, K. L.
    Chung, R. T.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S292 - S292
  • [34] Impact of gender on virologic responses rates in genotype 1 chronic hepatitis C patients with peginterferon alfa-2a and ribavirin treatment
    Yu, J. -W.
    Sun, L. -J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S86 - S86
  • [35] Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response
    Ferenci, Peter
    Laferl, Hermann
    Scherzer, Thomas-Matthias
    Maieron, Andreas
    Hofer, Harald
    Stauber, Rudolf
    Gschwantler, Michael
    Brunner, Harald
    Wenisch, Christoph
    Bischof, Martin
    Strasser, Michael
    Datz, Christian
    Vogel, Wolfgang
    Loeschenberger, Karin
    Steindl-Munda, Petra
    GASTROENTEROLOGY, 2010, 138 (02) : 503 - U126
  • [36] Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in Belgium : a sub-analysis of the PROPHESYS study
    Mulkay, J. P.
    Bourgeois, S.
    Lasser, L.
    De Galocsy, C.
    Tomasovic, S.
    Horsmans, Y.
    Van Vlierberghe, H.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77 (01) : 30 - 40
  • [37] Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
    Roeder, Claudia
    Jordan, Sabine
    zur Wiesch, Julian Schulze
    Pfeiffer-Vornkahl, Heike
    Hueppe, Dietrich
    Mauss, Stefan
    Zehnter, Elmar
    Stoll, Sabine
    Alshuth, Ulrich
    Lohse, Ansgar W.
    Lueth, Stefan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10984 - 10993
  • [38] Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
    Claudia Roeder
    Sabine Jordan
    Julian Schulze zur Wiesch
    Heike Pfeiffer-Vornkahl
    Dietrich Hueppe
    Stefan Mauss
    Elmar Zehnter
    Sabine Stoll
    Ulrich Alshuth
    Ansgar W Lohse
    Stefan Lueth
    World Journal of Gastroenterology, 2014, (31) : 10984 - 10993
  • [39] PATIENT REPORTED OUTCOMES AMONG CHRONIC HEPATITIS C PATIENTS RETREATED WITH PEGINTERFERON ALFA-2A/RIBAVIRIN AFTER NON-RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN IN SPAIN
    Olveira, A.
    Rincon, D.
    Diago, M.
    Crespo, J.
    Calleja, J. L.
    Salmeron, J.
    Andrade, R.
    Romero, M.
    VALUE IN HEALTH, 2011, 14 (07) : A282 - A282
  • [40] Clinical and persistency outcomes in hepatitis C patients treated with peginterfercin alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, Tarek
    Ye, Xin
    Chu, Teng-Chiao
    Brixner, Diana
    GASTROENTEROLOGY, 2008, 134 (04) : A833 - A833